Riociguat

Riociguat API (CAS No: 625115-55-1) is expertly produced at Amber Lifesciences Pvt. Ltd. in state-of-the-art GMP-compliant and ISO 9001:2015 certified manufacturing facilities, ensuring superior purity, batch-to-batch consistency, and compliance with international regulatory standards. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) and Material Safety Data Sheet (MSDS), aligned with USP/EP pharmacopeial guidelines.

Riociguat is a soluble guanylate cyclase (sGC) stimulator indicated for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It functions by enhancing the nitric oxide signaling pathway, leading to vasodilation and improved exercise capacity. Our API is subjected to rigorous quality assurance and validated manufacturing processes to ensure excellent performance in pharmaceutical formulations.

Amber Lifesciences serves pharmaceutical companies, formulation partners, exporters, shippers, Manufactures, and distributors across Asia, Europe, the Middle East, and LATAM regions, ensuring reliable supply chains, technical guidance, and complete regulatory support to facilitate smooth product registration and fast market access.

Storage & Transportation

Classified as non-Dangerous Goods. Store at controlled room temperature (20°C to 25°C / 68°F to 77°F), protected from light, moisture, and heat. Handle using standard pharmaceutical transport and storage procedures.